Giuseppina Brancaccio

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Anti Inflammatory

Prognostic Factors

Top Venues

Alimentary pharmacology & therapeutics

Scientific reports

Hepatology (Baltimore, Md.)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Massimo Bellato, Marco Cappellato, Francesca Longhin, Claudia Del Vecchio, Giuseppina Brancaccio, Anna Maria Cattelan, Paola Brun, Claudio Salaris, Ignazio Castagliuolo, Barbara Di Camillo
Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 + . Scientific reports 13 (1) (2023)
Loreta Anesti Kondili, Monica Monti, Maria Giovanna Quaranta, Laura Gragnani, Valentina Panetta, Giuseppina Brancaccio, Cesare Mazzaro, Marcello Persico, Mario Masarone, Gentile Ivan, Pietro Andreone, Salvatore Madonia, Elisa Biliotti, Roberto Filomia, Massimo Puoti, Anna Ludovica Fracanzani, Diletta Laccabue, Donatella Ieluzzi, Carmine Coppola, Maria Grazia Rumi, Antonio Benedetti, Gabriella Verucchi, Barbara Coco, Liliana Lc Chemello, Andrea Iannone, Alessia Ciancio, Francesco Paolo Russo, Francesco Barbaro, Filomena Morisco, Luchino Chessa, Marco Massari, Pierluigi Blanc, Anna Linda Zignego
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort. Hepatology (Baltimore, Md.) 76 (1) (2022)
Claudia Del Vecchio, Bethan Cracknell Daniels, Giuseppina Brancaccio, Alessandra Rosalba Brazzale, Enrico Lavezzo, Constanze Ciavarella, Francesco Onelia, Elisa Franchin, Laura Manuto, Federico Bianca, Vito Cianci, Anna Maria Cattelan, Ilaria Dorigatti, Stefano Toppo, Andrea Crisanti
Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants. Nature communications 13 (1) (2022)
Giuseppina Brancaccio, Giovanni Battista Gaeta
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting-authors' reply. Alimentary pharmacology & therapeutics 51 (4) (2020)
Giuseppina Brancaccio, Massimo Fasano, Adriano Grossi, Teresa Antonia Santantonio, Giovanni Battista Gaeta
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir. Alimentary pharmacology & therapeutics 49 (8) (2019)